Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
|Official Title:||Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders|
- PCP follow-up rates will be used to evaluate the efficacy of text message reminders. [ Time Frame: PCP follow-up rates will be assessed 7-14 days after discharge from the ED. ] [ Designated as safety issue: No ]
- Number of adolescents who accept text message reminders as an measure of feasibility and acceptability. [ Time Frame: 7-14 days after discharge from the ED ] [ Designated as safety issue: No ]The acceptability among adolescents of using text message reminders after ED discharge in adolescents treated in a pediatric ED.
- Number of adolescents satisfied with ED care between the control group and intervention group as a measure of patient satisfaction. [ Time Frame: 7-14 days after ED discharge ] [ Designated as safety issue: No ]Patient satisfaction of ED care when receiving text message reminders.
- Type of participant characteristics associated with PCP follow-up as a measure of behavior change, compliance and rate of follow-up care [ Time Frame: 7-14 days after ED discharge ] [ Designated as safety issue: No ]Patient characteristics associated with PCP follow-up
- Barriers to PCP follow-up from an ED visit to measure use of text message technology and rate of change in follow-up care between groups [ Time Frame: 7-14 days after ED visit ] [ Designated as safety issue: No ]Types of barriers encountered to PCP follow-up from an ED visit for PID care to measure rate of change in follow-up care between groups
|Study Start Date:||February 2011|
|Estimated Study Completion Date:||July 2014|
|Estimated Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
Experimental: Text Message Reminders
Subjects randomized to the the intervention group will receive a total of 4 text messages on days 2 through 5 to remind them to schedule and attend a PCP follow-up appointment
Behavioral: Text Message Reminders
Patients in the intervention group will receive text messages on their cell phones following discharge from the emergency department reminding them to make an appointment with their primary care provider. Text messages will be sent daily for 4 days after discharge from the ED.
Other Name: Text message reminders
No Intervention: Control Group
The control group will not receive any additional reminders to follow-up with PCP.
The Centers for Disease Control (CDC) recommends that patients diagnosed with pelvic inflammatory disease (PID) receive follow-up care within 72 hours of diagnosis. However, recent studies show that the majority of teenage girls diagnosed with PID do not receive this follow-up care within 72 hours. We hypothesize that text message reminders to girls diagnosed with PID in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.
|Contact: Frances Balamuth, MD, PhDfirstname.lastname@example.org|
|Contact: Cynthia Mollen, MDemail@example.com|
|United States, Pennsylvania|
|The Children's Hospital of Philadelphia||Recruiting|
|Philadelphia, Pennsylvania, United States, 19104|
|Contact: Margaret Wolff, MD firstname.lastname@example.org|
|Contact: Steve Yakscoe email@example.com|
|Sub-Investigator: Margaret Wolff, MD|
|Sub-Investigator: Esther Sampayo, MD, MPH|
|Principal Investigator: Cynthia Mollen, MD, MSCE|
|Sub-Investigator: Frances Balamuth, MD, PhD|
|Principal Investigator:||Cynthia Mollen, MD, MSCE||Children's Hospital of Philadelphia|
|Study Director:||Frances Balamuth, MD, PhD||Children's Hospital of Philadelphia|